Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloon Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barretts Epithelium (COLDPLAY 3)
|Male and Female Patients
|U.S. Govt. ID:
|Research Nurse Navigator: 212-342-5162 / firstname.lastname@example.org
C2 Therapeutics is currently enrolling patients to participate in the Coldplay 3 clinical trial. Coldplay 3 is evaluating the effectiveness of the Coldplay CryoBalloon Focal Ablation System in patients with Barrett's esophagus who have not yet received treatment. Participants will undergo treatment with the Coldplay CryoBalloon Focal Ablation System and report their level of discomfort and difficulty swallowing during the first seven days after the procedure. Follow-up appointments for the first year after treatment will be conducted every 10 weeks until an endoscopic exam and biopsy reveal no Barrett's esophagus.
This study is closed
Julian Abrams, MD
|Do you have Barrett's esophagus that is dysplastic (low-grade or high-grade)?
|Have you had previous treatment?